Sunshine Biopharma Inc. warrant (SBFMW)

• Market cap: $506K
• 1 day: 0.00%
• 5 days: -14.70%
• 1 month: -31.80%
• 3 months: -75.47%
• 6 months: -10.82%
• Year to date: 22.09%
• 1 year: 40.14%
• 5 years: -67.30%
• 10 years: -67.30%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Employees: 52

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

77% more capital invested

Capital invested by funds: $6.87K [Q4 2024] → $12.2K (+$5.31K) [Q1 2025]

50% more funds holding

Funds holding: 2 [Q4 2024] → 3 (+1) [Q1 2025]

0.88% more ownership

Funds ownership: 2.14% [Q4 2024] → 3.02% (+0.88%) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1